November 2023

Big step forward in launching OX124 in the US UPPSALA, Sweden, Nov. 2, 2023 /PRNewswire/ — Q3 2023 highlights›     Total net revenues of SEK 156.1 m (161.0)›     EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-­repeating ­­clinical trial

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: